![](/img/cover-not-exists.png)
2805 Overall survival gain with lenvatinib vs. placebo in radioactive iodine refractory differentiated thyroid cancer (RR-DTC): An updated analysis
Guo, M., Sherman, S., Wirth, L., Schlumberger, M., Dutcus, C., Robinson, B., Tahara, M., Latimer, N.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31549-0
Date:
September, 2015
File:
PDF, 56 KB
english, 2015